US FDA's 510(k) improvement plan sidesteps controversial reforms
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has issued a 25-point action plan which it intends to implement during 2011 to improve its 510(k) medical device regulatory clearance.